Abstract
Intrauterine inflammation from chorioamnionitis (CA) is associated with placental dysfunction and increased risk of bronchopulmonary dysplasia (BPD), the chronic lung disease of prematurity. Antenatal steroid (ANS) treatment improves early respiratory outcomes for premature infants. However, it remains unclear whether ANS improve long-term respiratory outcomes, and whether these effects are mediated through improvement of placental dysfunction and/or direct impact on the fetal lung. We hypothesized that maternal ANS therapy preserves long-term lung development and impacts placental structural changes and gene expression in experimental CA with features of BPD. Pregnant rat dams were administered either saline (CTL), intraamniotic (IA) endotoxin (ETX), ETX plus intramuscular (IM) betamethasone (ETX+BETA) or IM BM alone (BETA) on embryonic day 20 (e20). We collected placental tissue at delivery (e22) and infant lung tissue on day of life (DOL)14. In comparison with controls, IA ETX had impaired infant lung growth and function. Maternal BM treatment of ETX-exposed pregnant dams reduced infant total lung resistance by 15.3% (p<0.05), improved infant lung compliance by 9.5% (p<0.05), preserved alveolar and vascular growth (p<0.05), and improved RVH by 42.4% (p<0.05). ETX+BETA pregnancies were also associated with normalization of placental spiral artery modification and altered placental gene expression. These included upregulation of placental prolactin which has regulatory effects on pregnancy homeostasis and has been clincially associated with decreased BPD risk. The current study identifies parallel lung and placental changes associated with ANS treatment, providing a foundation for future studies to identify alternate antenatal therapies with more specific efficacy for BPD prevention.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
More From: American journal of physiology. Lung cellular and molecular physiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.